HIV treatment showdown: which combo works best for Late-Stage patients?
Disease control
Completed
This study compared two different HIV drug combinations in 447 people with advanced HIV (late presenters). One group received a protease inhibitor combo (Symtuza), the other an integrase inhibitor combo (Biktarvy). The goal was to see which works better and has fewer side effects…
Phase: PHASE3 • Sponsor: NEAT ID Foundation • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC